Results 281 to 290 of about 118,506 (311)

Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial

Lancet, The, 2019
Désirée M Van Der Heijde, Atul Deodhar, Mrcp, Filip E Van Den Bosch   +2 more
exaly  

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial

Lancet, The, 2018
Désirée M Van Der Heijde, Xenofon Baraliakos, Lianne S Gensler   +2 more
exaly  

Ankylosing spondylitis, spondylitis

2011
openaire   +1 more source

Ankylosing spondylitis

The Journal of Pediatrics, 1969
J J, Calabro, R M, Katz, B A, Maltz
openaire   +2 more sources

Impact of sex on inheritance of ankylosing spondylitis: a cohort study

Lancet, The, 1999
Sinead Brophy
exaly  

Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

Nature Genetics, 2010
John D Reveille, Paul Leo, Xiaodong Zhou
exaly  

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

New England Journal of Medicine, 2015
Joachim Sieper, Xenofon Baraliakos, Maxime Dougados   +2 more
exaly  

Ankylosing Spondylitis

Clinical Orthopaedics and Related Research, 1964
J, Edeiken, A, DePalma, P J, Hodes
openaire   +2 more sources

Ankylosing Spondylitis

2008
Liebscher, T, Min, K, Boos, N
openaire   +2 more sources

Ankylosing spondylitis

Postgraduate Medicine, 1982
openaire   +2 more sources